New Hope for Sickle Cell Disease: Groundbreakin...

By Staff Writer

July 19, 2023

The Institute for Clinical and Economic Review (ICER) has released an updated Evidence Report assessing the potential impact of two revolutionary gene therapies for sickle cell disease (SCD) - exagamglogene autotemc...
Revolutionizing Lung Cancer Detection: The Role of AI-Derived CAD Software
Revolutionising Oncology Medicine: A Precision Approach that Cuts Costs and B...
Multiple myeloma is the second most common type of blood cancer, with approxi...
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Eval...
HIQA’s Report on Repatriating Paediatric Stem Cell Transplants